ArticleJournal of experimental & clinical cancer research : CR2024

A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells.

Chunyan Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.